# Martin Bornhäuser

Source: https://onco.cc/people/martin-bornhauser/  
OnCo record `martin-bornhauser` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Dresden haematologist and transplant physician who co-directs the NCT/UCC Dresden cancer centre and leads AML transplant trials.

## Summary

Martin Bornhäuser is one of three Managing Directors of the National Center for Tumor Diseases (NCT/UCC) Dresden and Director of Medizinische Klinik und Poliklinik I at University Hospital Carl Gustav Carus. His research focuses on allogeneic stem cell transplantation and acute myeloid leukaemia, including the ASAP trial of immediate transplantation in relapsed or refractory AML. His role is listed on the NCT/UCC Direktorium page.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; haematology; leukaemia
- Role: Managing Director (Geschäftsführender Direktor); Director, Medizinische Klinik und Poliklinik I
- Specialisms: Haematology; Stem cell transplantation; Acute myeloid leukaemia; Multiple myeloma

## Sources

- Institution profile: https://www.nct-dresden.de/de/das-nctucc-dresden/organisation/direktorium
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Bornhauser+M%5BAuthor%5D

## Connected records

- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- institutions: [NCT/UCC Dresden, University Hospital Carl Gustav Carus](https://onco.cc/institutions/nct-dresden/)

---
JSON: https://onco.cc/api/v1/entities/martin-bornhauser.json